Top News: Anesthesia Reversal Drugs Market Advancements 2016 – 2023

Admin

4 years ago

The anesthesia reversal drugs are used to reverse the effects of sedatives, narcotics, and analgesic drugs when the effects of these drugs are no longer required during and after medical treatment
These drugs are also used when patients are highly sensitive to the anesthetic agents and anesthetic effects needs to be reduced or reversed

Table of Contents

Anesthesia reversal drugs are most commonly used to reverse the effects of neuromuscular blocking agents used during the surgical procedures. Anesthesia reversal drugs are used to prevent recurarization arising from high dosage of neuromuscular blocking agents.
The anesthesia reversal drugs are broadly categorized into receptor specific antagonists and non-specific analeptic agents
Commonly used anesthesia reversal drugs are anticholinesterases, flumazenil, naloxone, theophylline, doxapram, and caffeine

Increase in number of different surgical procedures especially neuromuscular surgeries, high prevalence and rise in incidence rates of orthopedic disorders requiring surgical treatments, and rise in usage of opioids and sedative agents across the globe primarily drive the global anesthesia reversal drugs market
Potential usage of opioids, local anesthetics (LA), potent sedatives, and neuromuscular blocking agents in surgical procedures are one of the prominent factors driving the anesthesia reversal drugs market during the forecast period
Moreover, development and commercialization of new anesthesia reversal drugs such as dexmedetomidine, rocuronium, and gantacurium in recent years is estimated to drive the growth of the market during the forecast period
On the contrary, factors such as the stringent rules and regulations regarding the adoption of balanced anesthesia, advent of short and ultra-short anesthesia acting drugs, and rise in awareness about possible side effects of over dosage of anesthesia drugs among anesthetics are estimated to restrain the growth of the market during the forecast period

Get PDF Sample Copy of Report: (Including TOC, List of Tables & Figures, Chart) : https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=76801

In terms of drugs, the global anesthesia reversal drugs market can be segmented into neuromuscular blockade reversing agents, opioid antagonists, sedative reversal drugs, coagulant reversal drugs, analeptic agents, and others. The neuromuscular blockade reversing agents segment in projected to dominate the global market during the forecast period.
The neuromuscular blockade reversing agents segment is further segmented into anticholinesterases, sugammadex , cysteine, and others
The neuromuscular blockade reversing agents are in routine use in the North America whereas the usage of these drugs is very limited in countries in Europe

In terms of route of administration, the global anesthesia reversal drugs market is segmented into intravenous route, intramuscular, nasal route, oral, and others. The intravenous route of administration segment is projected to dominate the global market during the forecast period.
The majority of anesthesia reversal drugs are available in intravenous route dosage form. High absorption rates of drugs through intravenous route and faster recovery have made the intravenous route as the first choice of route of administration for the anesthesia reversal drugs.

In terms of end-user, the global anesthesia reversal drugs market is segmented into hospitals, ambulatory surgery centers, specialty clinics, and others. The hospitals segment is projected to dominate the global market during the forecast period.
Large number of surgical procedures performed at hospitals and rapid increase in number of new hospitals in emerging countries such as Brazil, Mexico, India, and China are estimated to contribute to dominant share of the segment during the forecast period

In terms of region, the global anesthesia reversal drugs market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America is projected to dominate the global market during the forecast period.
High prevalence of cancer, cardiovascular disorders, and orthopedic disorders in the region; well-established healthcare facilities in the region; and rapidly increasing number of geriatric population in the region are likely to contribute to dominant share of the region during the forecast period
The anesthesia reversal drugs market in Asia Pacific is projected to grow at the highest CAGR during the forecast period. The key factors responsible for the high CAGR in Asia Pacific are rapidly growing number of hospitals and ambulatory surgery centers, improving healthcare infrastructure, and rapidly growing population with cancer and orthopedic disorders in China and India.
Moreover, high growth rate of health care industry in Asia Pacific, easy access to health care facilities, and increase in investments in health care by leading market players in Asia Pacific are estimated to fuel the growth of the market in the region

Global Anesthesia Reversal Drugs Market, by Drug

Neuromuscular Blockade Reversing Agents
- Anticholinesterases
- Sugammadex
- Cysteine
- Others
Opioid Antagonists
- Naloxone
- Others
Sedative Reversal Drugs
- Flumazenil
- Atipamezole
Coagulant Reversal Drugs
Analeptic Agents
Others

Global Anesthesia Reversal Drugs Market, by Route of Administration

Global Anesthesia Reversal Drugs Market, by End-user

Global Anesthesia Reversal Drugs Market, by Region

North America
- U.S.
- Canada
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia & New Zealand
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa